Xeris Biopharma Holdings, Inc.

XERSNasdaq· Pharmaceutical Preparations

Price History

Revenue

$291.8M

▲ 43.7% YoY

Net Income

$554,000

▲ 101.0% YoY

EPS

$0.00

▲ 100.0% YoY

Cash

$111.0M

▲ 55.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.